Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bebo HealthXPAR:MLBBO 47 Receivables Turnover is 742.59 as of Dec. 2025. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,104 Retail - Cyclical companies, Bebo Health ranks better than 98.37% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Bebo Health's Revenue for the
six
months ended in Dec. 2025 was €25.25 Mil. Bebo Health's average Accounts Receivable for the
six
months ended in Dec. 2025 was €0.03 Mil.
Hence, Bebo Health's Receivables Turnover for the
six
months ended in Dec. 2025 was 742.59.
Bebo Health (XPAR:MLBBO) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Bebo Health Receivables Turnover Related Terms
Bebo Health Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Bebo Health's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLBBO vs CASY, WSM, DKS: Receivables Turnover Comparison
For the Specialty Retail subindustry, Bebo Health's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health Receivables Turnover vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Bebo Health's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bebo Health (XPAR:MLBBO) has a Receivables Turnover of 742.59 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Bebo Health and its competitors. According to the industry distribution chart, Bebo Health ranks #18 out of 1104 companies in the Retail - Cyclical industry, placing it in the top 1.6%.
Is Bebo Health's Receivables Turnover too high?
Bebo Health's current Receivables Turnover is 742.59. The Retail - Cyclical industry median Receivables Turnover is 19.44. Bebo Health's value of 742.59 is 3719.9% above this industry median. Based on the distribution chart, Bebo Health ranks #18 out of 1104 companies in the Retail - Cyclical industry, which is in the top quartile — a strong position relative to peers. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's Receivables Turnover compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Bebo Health ranks #18 out of 1104 companies for Receivables Turnover. This places Bebo Health in the top 2% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 19.44. Bebo Health's value of 742.59 is 3719.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Retail - Cyclical company?
The median Receivables Turnover among Retail - Cyclical companies is 19.44, based on 1,104 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bebo Health's current Receivables Turnover of 742.59 is 3719.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Bebo Health and its competitors. For the Retail - Cyclical industry, the median Receivables Turnover is 19.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current Receivables Turnover is 742.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.18 — trading 513.3% above its estimated fair value. The current Receivables Turnover is 742.59 and 3719.9% above the Retail - Cyclical industry median of 19.44. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current Receivables Turnover is 742.59 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.18 is trading 513.3% above its estimated GF Value™ of €0.03.
GuruFocus considers Bebo Health to be Significantly Overvalued.
Key valuation signals for XPAR:MLBBO:
Receivables Turnover: 742.59
GF Value™: €0.03 vs. price of €0.18 (513.3% above fair value)
Industry Position: 3719.9% above the Retail - Cyclical median (#18 of 1104)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 
